A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin b for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia Academic Article uri icon

Overview

MeSH Major

  • Amphotericin B
  • Antifungal Agents
  • Echinocandins
  • Fever of Unknown Origin
  • Neutropenia

abstract

  • Caspofungin and L-AmB were comparable in tolerability, safety, and efficacy as empiric antifungal therapy for persistently febrile neutropenic pediatric patients.

publication date

  • May 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/INF.0b013e3181da2171

PubMed ID

  • 20431381

Additional Document Info

start page

  • 415

end page

  • 20

volume

  • 29

number

  • 5